2023
PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion
Tang H, McNiff J, Glusac E, Ko C. PRAME‐negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion. Journal Of Cutaneous Pathology 2023, 50: 1001-1005. PMID: 37565491, DOI: 10.1111/cup.14505.Peer-Reviewed Original ResearchCognitive bias in pathology, as exemplified in dermatopathology
Ko C, Glusac E. Cognitive bias in pathology, as exemplified in dermatopathology. Human Pathology 2023, 140: 267-275. PMID: 36906184, DOI: 10.1016/j.humpath.2023.03.003.Peer-Reviewed Original Research
2022
Acute Epstein–Barr virus infection resembling cutaneous T‐cell lymphoma
Fan R, Baker C, Glusac E, Xu M, Gru A, Cohen J. Acute Epstein–Barr virus infection resembling cutaneous T‐cell lymphoma. Journal Of Cutaneous Pathology 2022, 50: 238-242. PMID: 36349388, DOI: 10.1111/cup.14357.Peer-Reviewed Original ResearchConceptsAcute Epstein-Barr virus infectionEpstein-Barr virus infectionCutaneous T-cell lymphomaT-cell lymphomaEBV infectionVirus infectionAcute EBV infectionChronic EBV infectionInfectious mononucleosisCutaneous eruptionCutaneous manifestationsErythema multiformeViral exanthemsLymphoproliferative disordersHistopathologic featuresPrimary infectionInfectionLymphomaDisordersMononucleosisExanthemMultiforme
2020
Melanoma in situ: Don't make the cure worse than the disease
Prassinos A, Glusac E, Leffell DJ. Melanoma in situ: Don't make the cure worse than the disease. Journal Of The American Academy Of Dermatology 2020, 85: 520. PMID: 32387662, DOI: 10.1016/j.jaad.2020.04.168.Peer-Reviewed Original Research
2008
Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus
Ma L, Bandarchi B, Glusac E. Fatal Subcutaneous Panniculitis‐Like T‐Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead‐Ringer for Lupus Erythematosus. Journal Of Cutaneous Pathology 2008, 32: 101-102. DOI: 10.1111/j.0303-6987.2005.320eh.x.Peer-Reviewed Original ResearchSubcutaneous panniculitis-like T-cell lymphomaPanniculitis-like T-cell lymphomaT-cell lymphomaLupus erythematosusLymphoid infiltratesFatal hemophagocytic syndromeInterstitial lymphoid infiltratePulmonary lymphoid infiltratesSimilar immunohistochemical profileVacuolar interface changesDense lymphocytic infiltrateDermal mucin depositionT-cell receptor gamma geneReceptor gamma geneHemophagocytic syndromeLung biopsyLymph nodesLymphocytic infiltrateMucin depositionSystemic involvementDermal mucinUlcerated plaquesMonoclonal rearrangementImmunohistochemical profileSkin biopsies
2007
Cutaneous Lymphomas
Subtil A, Glusac E. Cutaneous Lymphomas. Basic And Clinical Dermatology 2007, 401-412. DOI: 10.3109/9781420005455.027.Peer-Reviewed Original Research
2006
Reply
McNiff J, Subtil A, Cowper S, Lazova R, Glusac E. Reply. Journal Of Cutaneous Pathology 2006, 33: 764-764. DOI: 10.1111/j.1600-0560.2006.00547.x.Commentaries, Editorials and Letters
2004
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
Smith BD, Glusac EJ, McNiff JM, Smith GL, Heald PW, Cooper DL, Wilson LD. Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems. Journal Of Clinical Oncology 2004, 22: 634-639. PMID: 14966086, DOI: 10.1200/jco.2004.08.044.Peer-Reviewed Original ResearchConceptsCutaneous B-cell lymphomaPrimary cutaneous B-cell lymphomaLarge B-cellInitial biopsy specimensB-cell lymphomaFollicle center cellsB cellsOverall survivalBiopsy specimensFive-year relapse-free survivalEuropean OrganizationFive-year overall survivalCenter cellsRelapse-free survivalWHO classification systemExtracutaneous diseaseLocal radiotherapyIndolent coursePrimary outcomeInitial treatmentTreatment of cancerHistopathologic subtypePathologic classificationNoncutaneous sitesDLB
2003
Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case
Pol-Rodriguez M, Crane S, Feinberg D, Glusac E, Bolognia J. Palpable Purpura in an Asthmatic Woman With Eosinophilia—Quiz Case. JAMA Dermatology 2003, 139: 803-808. PMID: 12810518, DOI: 10.1001/archderm.139.6.803-a.Peer-Reviewed Case Reports and Technical Notes
2002
Differential Diagnosis in Dermatopathology II, 2nd Edition.
Glusac E. Differential Diagnosis in Dermatopathology II, 2nd Edition. American Journal Of Dermatopathology 2002, 24: 380. DOI: 10.1097/00000372-200208000-00023.Peer-Reviewed Original Research
2001
The eclipse naevus: tan centre with stellate brown rim
Schaffer J, Glusac E, Bolognia J. The eclipse naevus: tan centre with stellate brown rim. British Journal Of Dermatology 2001, 145: 1023-1026. PMID: 11899128, DOI: 10.1046/j.1365-2133.2001.04538.x.Peer-Reviewed Original ResearchRegulation of Cutaneous Malignancy by γδ T Cells
Girardi M, Oppenheim D, Steele C, Lewis J, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar R, Hayday A. Regulation of Cutaneous Malignancy by γδ T Cells. Science 2001, 294: 605-609. PMID: 11567106, DOI: 10.1126/science.1063916.Peer-Reviewed Original ResearchMeSH KeywordsAmino Acid SequenceAnimalsCarcinogensCell LineCytotoxicity, ImmunologicDimerizationEpidermisEpithelial CellsHistocompatibility Antigens Class IHumansImmunologic SurveillanceLigandsMembrane ProteinsMiceMice, Inbred C57BLMinor Histocompatibility AntigensMolecular Sequence DataNK Cell Lectin-Like Receptor Subfamily KProtein ConformationProtein FoldingReceptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, gamma-deltaReceptors, ImmunologicReceptors, Natural Killer CellRecombinant Fusion ProteinsReverse Transcriptase Polymerase Chain ReactionSkin NeoplasmsT-Lymphocyte SubsetsConceptsT cellsGammadelta cellsLocal T cellsNatural killer cellsΓδ T cellsGammadelta T cellsCytolytic T cellsSkin carcinoma cellsNKG2D engagementMultiple regimensKiller cellsCutaneous malignanciesCutaneous carcinogenesisEpithelial malignanciesRAE-1Human MICAMalignancyCarcinoma cellsSkin cellsCellsNKG2DRegimensMiceEpitheliumCarcinogenesisPointillist nevi
Huynha P, Glusac E, Bolognia J. Pointillist nevi. Journal Of The American Academy Of Dermatology 2001, 45: 397-400. PMID: 11511837, DOI: 10.1067/mjd.2001.116343.Peer-Reviewed Original ResearchConceptsMelanocytic neviHistologic featuresHistologic correlatesMelanocytic nestsJunctional melanocytic nestsAtypical melanocytic neviBenign melanocytic neviBenign melanocytic lesionsCutaneous melanomaHistologic examinationPerifollicular hypopigmentationPapillary dermisMelanocytic lesionsNeviBrown globulesUnusual patternOf cells and architecture: new approaches to old criteria in mycosis fungoides
Glusac E. Of cells and architecture: new approaches to old criteria in mycosis fungoides. Journal Of Cutaneous Pathology 2001, 28: 169-173. PMID: 11426823, DOI: 10.1034/j.1600-0560.2001.028004169.x.Peer-Reviewed Original ResearchAssessment of clonality in melanocytic nevi
Hui P, Perkins A, Glusac E. Assessment of clonality in melanocytic nevi. Journal Of Cutaneous Pathology 2001, 28: 140-144. PMID: 11168766, DOI: 10.1034/j.1600-0560.2001.028003140.x.Peer-Reviewed Original ResearchInduction of human tumor‐loaded dendritic cells
Berger C, Xu A, Hanlon D, Lee C, Schechner J, Glusac E, Christensen I, Snyder E, Holloway V, Tigelaar R, Edelson R. Induction of human tumor‐loaded dendritic cells. International Journal Of Cancer 2001, 91: 438-447. PMID: 11251964, DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1073>3.0.co;2-r.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, CDApoptosisCD36 AntigensCell DifferentiationCell DivisionCell SurvivalCells, CulturedCytokinesCytoplasmDendritic CellsDose-Response Relationship, DrugFlow CytometryHumansImmunoglobulinsImmunohistochemistryImmunophenotypingImmunotherapyLeukapheresisLeukocytesLymphocytesMajor Histocompatibility ComplexMembrane GlycoproteinsMonocytesPhagocytosisPhenotypeT-LymphocytesTime FactorsConceptsExtracorporeal photopheresisDistinctive antigensTumor-loaded dendritic cellsStandard extracorporeal photopheresisMHC class II moleculesImproved cancer immunotherapyDendritic cell differentiationAnti-cancer vaccinesMalignant T cellsClass II moleculesTransition of monocytesDC vaccinesMalignant cell apoptosisDendritic cellsImmature DCsCancer immunotherapyCD83 expressionT cellsExogenous cytokinesSignificant proliferationCell apoptosisVaccineMembrane CD36Cell differentiationCellsBook reviews
Glusac E. Book reviews. Journal Of Cutaneous Pathology 2001, 28: 53-54. DOI: 10.1034/j.1600-0560.2001.280107-3.x.Peer-Reviewed Original Research
2000
Under The Microscope Surgeons, Pathologists, and Melanocytic Nevi
Lazova R, McNiff J, Glusac E. Under The Microscope Surgeons, Pathologists, and Melanocytic Nevi. Clinics In Plastic Surgery 2000, 27: 323-329. PMID: 10941556, DOI: 10.1016/s0094-1298(20)32731-0.Peer-Reviewed Original ResearchTh2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4
Herrick C, MacLeod H, Glusac E, Tigelaar R, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. Journal Of Clinical Investigation 2000, 105: 765-775. PMID: 10727445, PMCID: PMC377464, DOI: 10.1172/jci8624.Peer-Reviewed Original ResearchConceptsTh2 responsesIL-13IL-4Th2-type immune responseIL-4-deficient miceTh2-promoting cytokinesOVA-specific IgG1Bronchoalveolar lavage fluidWild-type miceAllergen encounterTh2 sensitizationAirway challengeTh2 activationAllergen exposureAtopic individualsBAL fluidEnvironmental allergensWT miceLavage fluidPrimary exposureVivo depletionAnatomic sitesImmune responseAnimal modelsMiceUnilesional cutaneous T-cell lymphoma: Clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant
Heald P, Glusac E. Unilesional cutaneous T-cell lymphoma: Clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant. Journal Of The American Academy Of Dermatology 2000, 42: 283-285. PMID: 10642687, DOI: 10.1016/s0190-9622(00)90140-3.Peer-Reviewed Original Research